Macrogenics Q2 EPS $(0.89) Misses $(0.59) Estimate, Sales $10.80M Miss $21.24M Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:38pm
Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.59) by 50.85 percent. This is a 196.74 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $10.80 million which missed the analyst consensus estimate of $21.24 million by 49.16 percent. This is a 17.81 percent decrease over sales of $13.14 million the same period last year.

Posted In: MGNX